did serena williams use glp-1 reveals she's been taking a medication to help her with weight loss, and she's down 31 pounds. She's launching a campaign with the health care company Ro to normalize Serena Williams went public saying

The Evidence: Allulose and GLP-1 A growing body of research supports the link between allulose consumption and GLP-1 release

For over two decades, GLP-1 has been heavily investigated as the most promising therapy target in type 2 diabetes patients

Semaglutide, as a GLP-1 receptor agonist, has specific effects on various organs, including the small intestine, stomach, pancreas, and brain

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration strategies for users.

#AskTheIMF

To unlock wider and more equitable access to novel obesity treatments, however, positive cardiovascular outcomes data will be absolutely critical to demonstrate substantial cost-savings for health systems from medication-assisted weight loss by avoiding downstream complications from obesity-related comorbidities